Nordic Group BV
https://www.nordicpharmagroup.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Nordic Group BV
AstraZeneca/Daiichi Sankyo’s Enhertu To Get Lung Cancer Label For EU
The European Medicines Agency has recommended new uses for 11 approved medicines, including an antibody drug conjugate for treating advanced non-small cell lung cancer.
Keytruda & Bavencio Win EU Nod For More Cancers
The European Medicines Agency has recommended that the therapeutic indications of Keytruda and Bavencio should be expanded again.
Deals Shaping The Medical Industry, February 2017
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in January 2017
Taiho Oncology Prepares To Commercialize Products In U.S., Europe
The business unit is transitioning from being the clinical development arm of its parent company to a full-blown commercial operation in the U.S. and Europe.
Company Information
- Industry
- Biotechnology
- Distributors
- Pharmaceuticals
- Services
-
Services
- Hospitals, Nursing Homes, Institutions
-
Biotechnology
- Large Molecule
- Other Names / Subsidiaries
-
- Nordic Drugs
- Nordic Pharma
- Disphar International
- Indeus Life Sciences
- Prague Clinical Services
- QPharma
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice